Research
Print page Print page
Switch language
Rigshospitalet - a part of Copenhagen University Hospital
Published

Loss of TET2 in hematopoietic cells leads to DNA hypermethylation of active enhancers and induction of leukemogenesis

Research output: Contribution to journalJournal articleResearchpeer-review

DOI

  1. Parental Acceptance Rate of Testicular Tissue Cryopreservation in Danish Boys with Cryptorchidism

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Human RTEL1 associates with Poldip3 to facilitate responses to replication stress and R-loop resolution

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Sertoli Cell Number Correlates with Serum Inhibin B in Infant Cryptorchid Boys

    Research output: Contribution to journalJournal articleResearchpeer-review

  4. Surgical Management of Undescended Testis - Timetable and Outcome: A Debate

    Research output: Contribution to journalReviewResearchpeer-review

  5. ERG promotes the maintenance of hematopoietic stem cells by restricting their differentiation

    Research output: Contribution to journalJournal articleResearchpeer-review

  1. The EHA Research Roadmap: Normal Hematopoiesis

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Targeted inhibition of cooperative mutation- and therapy-induced AKT activation in AML effectively enhances response to chemotherapy

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Quantitative single-cell proteomics as a tool to characterize cellular hierarchies

    Research output: Contribution to journalJournal articleResearchpeer-review

  4. Basement membrane stiffness determines metastases formation

    Research output: Contribution to journalJournal articleResearchpeer-review

  5. The ASXL1-G643W variant accelerates the development of CEBPA mutant acute myeloid leukemia

    Research output: Contribution to journalJournal articleResearchpeer-review

View graph of relations

DNA methylation is tightly regulated throughout mammalian development, and altered DNA methylation patterns are a general hallmark of cancer. The methylcytosine dioxygenase TET2 is frequently mutated in hematological disorders, including acute myeloid leukemia (AML), and has been suggested to protect CG dinucleotide (CpG) islands and promoters from aberrant DNA methylation. In this study, we present a novel Tet2-dependent leukemia mouse model that closely recapitulates gene expression profiles and hallmarks of human AML1-ETO-induced AML. Using this model, we show that the primary effect of Tet2 loss in preleukemic hematopoietic cells is progressive and widespread DNA hypermethylation affecting up to 25% of active enhancer elements. In contrast, CpG island and promoter methylation does not change in a Tet2-dependent manner but increases relative to population doublings. We confirmed this specific enhancer hypermethylation phenotype in human AML patients with TET2 mutations. Analysis of immediate gene expression changes reveals rapid deregulation of a large number of genes implicated in tumorigenesis, including many down-regulated tumor suppressor genes. Hence, we propose that TET2 prevents leukemic transformation by protecting enhancers from aberrant DNA methylation and that it is the combined silencing of several tumor suppressor genes in TET2 mutated hematopoietic cells that contributes to increased stem cell proliferation and leukemogenesis.

Original languageEnglish
JournalGenes & Development
Volume29
Issue number9
Pages (from-to)910-22
Number of pages13
ISSN0890-9369
DOIs
Publication statusPublished - 1 May 2015

ID: 45362735